RENAISSANCE TECHNOLOGIES LLC

Position in ACLX — Arcellx, Inc.

CIK 1037389 NEW YORK, NY

Position in ACLX

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$11,068,648

+$6,607,848 QoQ

Shares Held

96,400

+41.8% QoQ

Ownership

0.165%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2022

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

RENAISSANCE TECHNOLOGIES LLC holds $3,467,670,450 across 330 Biotechnology names. ACLX ranks #49 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	13,726,993	$588,750,729
2	INCY	Incyte Corp	3,651,532	$343,682,191
3	CORT	Corcept Therapeutics Inc	5,682,783	$229,072,982
4	VRTX	Vertex Pharmaceuticals Inc / Ma	421,688	$188,300,559
5	JAZZ	Jazz Pharmaceuticals plc	819,374	$154,902,654
6	GMAB	Genmab A/S	4,414,550	$118,442,376
7	INVA	Innoviva, Inc.	4,055,632	$94,496,225
8	ARWR	Arrowhead Pharmaceuticals, Inc.	1,036,495	$64,988,236

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$11,068,648	96,400	+41.8%	Shares	Sole	2026-05-14
2025-03-31	$4,460,800	68,000	+38.5%	Shares	Sole	2025-05-14
2024-12-31	$3,765,479	49,100	+81.4%	Shares	Sole	2025-02-13
2024-06-30	$1,494,103	27,072	-55.7%	Shares	Sole	2024-08-09
2023-12-31	$3,391,050	61,100	+13.6%	Shares	Sole	2024-02-13
2023-09-30	$1,930,344	53,800	-84.4%	Shares	Sole	2023-11-14
2023-06-30	$10,898,370	344,667	+1988.9%	Shares	Sole	2023-08-11
2023-03-31	$508,365	16,500	-67.5%	Shares	Sole	2023-05-12
2022-12-31	$1,573,784	50,800	+90.3%	Shares	Sole	2023-02-13
2022-06-30	$482,736	26,700	—	Shares	Sole	2022-08-12
No filing history on record for this holder in this stock.